| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |